Where people get into trouble is they either want to slather toxins called sunscreen all over themselves then sit in the hot sun so those toxins are then driven into their bodies through their skin, which is your bodies biggest eliminative organ….however it also is the biggest organ to absorb.
Our bodies can’t process 3-4-5 hours of constant tanning, the amount of rays damages the liver mainly because it is too big a load for the body to process. If you want a tan do it wisely each day as your body can handle it.
God gave us the sun not only to grow our foods, to warm us, to keep us healthy and unfortunately we once again relied on the myths of the medical profession to take this valuable source away from us.
Now here is the article….
Over the past few decades, people have become increasingly aware of the risks associated with excessive exposure to UV radiation from sunlight, including skin cancer, photoaging, and cataracts.
However, appropriate sun exposure provides benefits that are crucial for human health. Growing evidence suggests that sun exposure not only helps prevent and treat a variety of diseases, but insufficient exposure to sunlight may also increase the risk of cancer.
Sun Exposure Increases Skin Cancer Risk, but May Prevent Other Types of Cancer
Many people associate sun exposure with skin cancer, but research has found that insufficient exposure to UV radiation may also be linked to other types of cancer.
Before delving into this topic, we first need to understand the relationship between sunlight, UV radiation, and vitamin D.
Energy from the sun reaches the Earth in the form of visible light, infrared radiation, and ultraviolet radiation. Ultraviolet radiation is further divided into three types: UVA, UVB, and UVC, of which only UVA and UVB reach the Earth’s surface. UVC is absorbed by the atmosphere.
UVB in sunlight is absorbed by cholesterol in the skin and converted to vitamin D3. Vitamin D3 is then metabolized in the liver to 25-hydroxyvitamin D (also known as calcidiol) and in the kidneys to its biologically active form (calcitriol), according to a 2004 article in The American Journal of Clinical Nutrition.
According to that article, the only way to determine a person’s vitamin D level is to measure the concentration of 25-hydroxyvitamin D in their blood. This 25-hydroxyvitamin D has a half-life of approximately two weeks and is the major circulating form of vitamin D.
In 2022, a study published in the journal Nutrients found that, based on ecological studies of cancer related to solar radiation, sun exposure may decrease the incidence and mortality risks of approximately 23 types of cancer. According to an article in Environmental Health Perspectives, compared to those who live in regions with longer sunlight exposure, people living at high latitudes with less sunlight exposure have an increased mortality risk from Hodgkin’s lymphoma, as well as colon, breast, ovarian, prostate, pancreatic, and other types of cancer.
According to the Nutrients study, meta-analyses of multiple observational studies have shown that there is a significant negative correlation between the concentration of 25-hydroxyvitamin D in the blood and the incidence of 12 different types of cancer, indicating that higher levels of 25-hydroxyvitamin D are associated with a lower incidence of cancer.
American researchers conducted a meta-analysis of two randomized clinical trials and one prospective cohort and found that among 5,038 women, the group with the highest 25-hydroxyvitamin D concentration (≥60 ng/ml) had an 82 percent lower incidence of breast cancer compared to the group with the lowest concentration (<20 ng/ml). The same group had an 80 percent lower risk of developing breast cancer compared to those with the lowest concentration of 25-hydroxyvitamin D, after adjusting for age, BMI, smoking status, and calcium supplement intake.
Another meta-analysis found that breast cancer patients with the highest concentration of 25-hydroxyvitamin D had a death rate of approximately half that of those with the lowest concentration. In a clinical trial, over 2,300 women aged 55 and above residing in Nebraska consumed 2,000 IU of vitamin D3 (two to four times the daily suggestion) and 1,500 milligrams of calcium daily. The results showed that in the subsequent two to four years, individuals who achieved a blood concentration of 25-hydroxyvitamin D at 55 ng/ml had a 35 percent lower risk of developing cancer compared to those with a concentration of 30 ng/ml.
A meta-analysis of five studies found that individuals with a serum 25-hydroxyvitamin D concentration less than or equal to 12 ng/ml had a 50 percent higher risk of colorectal cancer compared to those with a concentration of 33 ng/ml or greater.